[ Price : $8.95]
Researchers say they see no evidence of continuing problems with generic drug 180-day exclusivity parking that require a congressi...[ Price : $8.95]
Astellas says an ASPIRO trial patient whose serious adverse event led to the trial being paused and an FDA clinical hold has died.[ Price : $8.95]
Two leading House Republicans ask FDA for information on the pressure they say may have come from the White House to approve Covid...[ Price : $8.95]
FDA acting commissioner Janet Woodcock asks the U.S. Patent and Trademark Office to open a dialog on how the two agencies can work...[ Price : $8.95]
Jacobus Pharmaceutical recalls three lots of Ruzurgi (amifampridine) 10 mg tablets due to potential contamination with yeast, mold...[ Price : $8.95]
FDA clears an inTravent Medical Partners 510(k) for the SoloPass system for aiding in the frontal placement of intra-ventricular c...[ Price : $8.95]
FDA accepts for review an Axsome Therapeutics NDA for AXS-07 (meloxicam-rizatriptan) for treating migraine headaches.[ Price : $8.95]
FDA grants Nyxoah a breakthrough device designation for its Genio bilateral hypoglossal nerve stimulation system and its use in tr...